Zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer

DMM Disease Models and Mechanisms

Volumn 7, Issue 7, 2014, Pages 883-894

  Schiavone, Marco ^a   Rampazzo, Elena ^a   Casari, Alessandro ^a   Battilana, Giusy ^a   Persano, Luca ^a   Moro, Enrico ^a   Liu, Shu ^b   Leach, Steve D ^b   Tiso, Natascia ^a   Argenton, Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

KRAS; Medulloblastoma; Notch; Pancreatic adenocarcinoma; Reporters; Shh; TGF ; Zebrafish

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CYCLINE; ENHANCED GREEN FLUORESCENT PROTEIN; NERVE CELL ADHESION MOLECULE; NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN; BIOLOGICAL MARKER; GREEN FLUORESCENT PROTEIN; KRAS PROTEIN, ZEBRAFISH; MUTANT PROTEIN; PROTEIN P21; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PTF1; ZEBRAFISH PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER MODEL; CELL PROLIFERATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; EMBRYO; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE EXPRESSION SYSTEM; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MEDULLOBLASTOMA; MESENCHYME CELL; NONHUMAN; ONCOGENE K RAS; OUTCROSSING; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; TRANSGENIC ZEBRAFISH; ADENOCARCINOMA; ANIMAL; ANTIBODY SPECIFICITY; CELL TRANSFORMATION; DISEASE COURSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; PANCREAS TUMOR; PATHOLOGY; TRANSGENIC ANIMAL; ZEBRA FISH;

ADENOCARCINOMA; ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOPTOSIS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; KAPLAN-MEIER ESTIMATE; MEDULLOBLASTOMA; MUTANT PROTEINS; ORGAN SPECIFICITY; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84903941890     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.014969     Document Type: Article

References (75)

1. Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S. and DePinho, R. A. (2003). Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 17, 3112-3126. (Pubitemid 38040774)
2. Aldinger, K. A. and Elsen, G. E. (2008). Ptf1a is a molecular determinant for both glutamatergic and GABAergic neurons in the hindbrain. J. Neurosci. 28, 338-339.
3. Aref, D., Moffatt, C. J., Agnihotri, S., Ramaswamy, V., Dubuc, A. M., Northcott, P. A., Taylor, M. D., Perry, A., Olson, J. M., Eberhart, C. G. et al. (2013). Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development. Brain Pathol. 23, 178-191.
4. Bailey, J. M. and Leach, S. D. (2012). Signaling pathways mediating epithelial-mesenchymal crosstalk in pancreatic cancer: Hedgehog, Notch and TGFβ. In Pancreatic Cancer and Tumor Microenvironment (ed. P. J. Grippo and H. G. Munshi), Chapter 7. Trivandrum, India: Transworld Research Network.
5. Bardeesy, N. and DePinho, R. A. (2002). Pancreatic cancer biology and genetics. Nat. Rev. Cancer 2, 897-909. (Pubitemid 37328891)
6. Bardeesy, N., Cheng, K. H., Berger, J. H., Chu, G. C., Pahler, J., Olson, P., Hezel, A. F., Horner, J., Lauwers, G. Y., Hanahan, D. et al. (2006). Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 20, 3130-3146. (Pubitemid 44790628)
7. Bhatia, B., Potts, C. R., Guldal, C., Choi, S., Korshunov, A., Pfister, S., Kenney, A. M. and Nahlé, Z. A. (2012). Hedgehog-mediated regulation of PPARã controls metabolic patterns in neural precursors and shh-driven medulloblastoma. Acta Neuropathol. 123, 587-600.
8. Chen, X., Liao, J., Lu, Y., Duan, X. and Sun, W. (2011). Activation of the PI3K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1. Pathol. Oncol. Res. 17, 257-261.
9. Conradt, L., Henrich, A., Wirth, M., Reichert, M., Lesina, M., Algul, H., Schmid, R. M., Kramer, O. H., Saur, D. and Schneider, G. (2012). Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death. Int. J. Cancer 132, 2248-2257.
10. Corallo, D., Schiavinato, A., Trapani, V., Moro, E., Argenton, F. and Bonaldo, P. (2013). Emilin3 is required for notochord sheath integrity and interacts with Scube2 to regulate notochord-derived Hedgehog signals. Development 140, 4594-4601.
11. Corcoran, R. B., Contino, G., Deshpande, V., Tzatsos, A., Conrad, C., Benes, C. H., Levy, D. E., Settleman, J., Engelman, J. A. and Bardeesy, N. (2011). STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res. 71, 5020-5029.
12. De La O, J. P., Emerson, L. L., Goodman, J. L., Froebe, S. C., Illum, B. E., Curtis, A. B. and Murtaugh, L. C. (2008). Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc. Natl. Acad. Sci. USA 105, 18907-18912.
13. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S. and Gauthier, J. M. (1998). Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100. (Pubitemid 28254381)
14. Elston, R. and Inman, G. J. (2012). Crosstalk between p53 and TGF-β Signalling. J. Signal Transduct. 2012, 294097.
15. Esposito, I., Seiler, C., Bergmann, F., Kleeff, J., Friess, H. and Schirmacher, P. (2007). Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment. Pancreas 35, 212-217. (Pubitemid 47482512)
16. Etchin, J., Kanki, J. P. and Look, A. T. (2011). Zebrafish as a model for the study of human cancer. Methods Cell Biol. 105, 309-337.
17. Ghosh, B. and Leach, S. D. (2011). p53: Guardian of pancreatic epithelial identity. Cell Cycle 10, 1717.
18. Gilbertson, R. J., Langdon, J. A., Hollander, A., Hernan, R., Hogg, T. L., Gajjar, A., Fuller, C. and Clifford, S. C. (2006). Mutational analysis of PDGFR-RAS/ MAPK pathway activation in childhood medulloblastoma. Eur. J. Cancer 42, 646-649. (Pubitemid 43343687)
19. Gironella, M., Seux, M., Xie, M. J., Cano, C., Tomasini, R., Gommeaux, J., Garcia, S., Nowak, J., Yeung, M. L., Jeang, K. T. et al. (2007). Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. USA 104, 16170-16175. (Pubitemid 350099380)
20. Goldsmith, J. R. and Jobin, C. (2012). Think small: zebrafish as a model system of human pathology. J. Biomed. Biotechnol. 2012, 817341.
21. Goonesinghe, A., Luan, X. M., Hurlstone, A. and Garrod, D. (2012). Desmosomal cadherins in zebrafish epiboly and gastrulation. BMC Dev. Biol. 12, 1.
22. Guessous, F., Li, Y. and Abounader, R. (2008). Signaling pathways in medulloblastoma. J. Cell. Physiol. 217, 577-583.
23. Hanahan, D. and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
24. Handra-Luca, A., Hammel, P., Sauvanet, A., Ruszniewski, P. and Couvelard, A. (2012). Tumoral epithelial and stromal expression of SMAD proteins in pancreatic ductal adenocarcinomas. J. Hepatobiliary Pancreat. Sci. 20, 294-302.
25. Heldin, C. H. and Moustakas, A. (2012). Role of Smads in TGFβ signaling. Cell Tissue Res. 347, 21-36.
26. Herreros-Villanueva, M., Hijona, E., Cosme, A. and Bujanda, L. (2012a). Mouse models of pancreatic cancer. World J. Gastroenterol. 18, 1286-1294.
27. Herreros-Villanueva, M., Zubia-Olascoaga, A. and Bujanda, L. (2012b). c-Met in pancreatic cancer stem cells: therapeutic implications. World J. Gastroenterol. 18, 5321-5323.
28. Hu, H., Zhou, L., Awadallah, A. and Xin, W. (2012). Significance of Notch1-signaling pathway in human pancreatic development and carcinogenesis. Appl. Immunohistochem. Mol. Morphol. 21, 242-247.
29. Jing, Y., Han, Z., Zhang, S., Liu, Y. and Wei, L. (2011). Epithelial-mesenchymal transition in tumor microenvironment. Cell Biosci 1, 29.
30. Jung, I. H., Jung, D. E., Park, Y. N., Song, S. Y. and Park, S. W. (2011). Aberrant Hedgehog ligands induce progressive pancreatic fibrosis by paracrine activation of myofibroblasts and ductular cells in transgenic zebrafish. PLoS ONE 6, e27941.
31. Kawakami, K., Imanaka, K., Itoh, M. and Taira, M. (2004). Excision of the Tol2 transposable element of the medaka fish Oryzias latipes in Xenopus laevis and Xenopus tropicalis. Gene 338, 93-98. (Pubitemid 39092415)
32. Kornmann, M., Tangvoranuntakul, P. and Korc, M. (1999). TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor. Int. J. Cancer 83, 247-254. (Pubitemid 29449105)
33. Kwan, K. M., Fujimoto, E., Grabher, C., Mangum, B. D., Hardy, M. E., Campbell, D. S., Parant, J. M., Yost, H. J., Kanki, J. P. and Chien, C. B. (2007). The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev. Dyn. 236, 3088-3099. (Pubitemid 350175006)
34. Kwon, S. M., Alev, C., Lee, S. H. and Asahara, T. (2012). The molecular basis of Notch signaling: a brief overview. Adv. Exp. Med. Biol. 727, 1-14.
35. Lin, J. W., Biankin, A. V., Horb, M. E., Ghosh, B., Prasad, N. B., Yee, N. S., Pack, M. A. and Leach, S. D. (2004). Differential requirement for ptf1a in endocrine and exocrine lineages of developing zebrafish pancreas. Dev. Biol. 270, 474-486. (Pubitemid 38748566)
36. Lirdprapamongkol, K., Chiablaem, K., Sila-Asna, M., Surarit, R., Bunyaratvej, A. and Svasti, J. (2012). Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines. Biochem. Biophys. Res. Commun. 422, 429-435.
37. Liu, S. and Leach, S. D. (2011). Screening pancreatic oncogenes in zebrafish using the Gal4/UAS system. Methods Cell Biol. 105, 367-381.
38. López-Rovira, T., Chalaux, E., Massagué, J., Rosa, J. L. and Ventura, F. (2002). Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 277, 3176-3185. (Pubitemid 34953179)
39. Lowy, A. M., Fenoglio-Preiser, C., Kim, O. J., Kordich, J., Gomez, A., Knight, J., James, L. and Groden, J. (2003). Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma. Ann. Surg. Oncol. 10, 284-290. (Pubitemid 40486962)
40. Maitra, A. and Leach, S. D. (2012). Disputed paternity: the uncertain ancestry of pancreatic ductal neoplasia. Cancer Cell 22, 701-703.
41. Manfroid, I., Ghaye, A., Naye, F., Detry, N., Palm, S., Pan, L., Ma, T. P., Huang, W., Rovira, M., Martial, J. A. et al. (2012). Zebrafish sox9b is crucial for hepatopancreatic duct development and pancreatic endocrine cell regeneration. Dev. Biol. 366, 268-278.
42. Marino, S. (2005). Medulloblastoma: developmental mechanisms out of control. Trends Mol. Med. 11, 17-22. (Pubitemid 40092670)
43. McCleary-Wheeler, A. L., McWilliams, R. and Fernandez-Zapico, M. E. (2012). Aberrant signaling pathways in pancreatic cancer: a two compartment view. Mol. Carcinog. 51, 25-39.
44. Moro, E., Vettori, A., Porazzi, P., Schiavone, M., Rampazzo, E., Casari, A., Ek, O., Facchinello, N., Astone, M., Zancan, I. et al. (2013). Generation and application of signaling pathway reporter lines in zebrafish. Mol. Genet. Genomics 288, 231-242.
45. Morris, J. P., 4th, Cano, D. A., Sekine, S., Wang, S. C. and Hebrok, M. (2010). Betacatenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J. Clin. Invest. 120, 508-520.
46. Mysliwiec, P. and Boucher, M. J. (2009). Targeting Notch signaling in pancreatic cancer patients - rationale for new therapy. Adv. Med. Sci. 54, 136-142.
47. Nakajima, S., Doi, R., Toyoda, E., Tsuji, S., Wada, M., Koizumi, M., Tulachan, S. S., Ito, D., Kami, K., Mori, T. et al. (2004). N-cadherin expression and epithelialmesenchymal transition in pancreatic carcinoma. Clin. Cancer Res. 10, 4125-4133. (Pubitemid 38812492)
48. Park, S. W., Davison, J. M., Rhee, J., Hruban, R. H., Maitra, A. and Leach, S. D. (2008). Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology 134, 2080-2090. (Pubitemid 351783259)
49. Parsons, M. J., Pisharath, H., Yusuff, S., Moore, J. C., Siekmann, A. F., Lawson, N. and Leach, S. D. (2009). Notch-responsive cells initiate the secondary transition in larval zebrafish pancreas. Mech. Dev. 126, 898-912.
50. Pascual, M., Abasolo, I., Mingorance-Le Meur, A., Martínez, A., Del Rio, J. A., Wright, C. V., Real, F. X. and Soriano, E. (2007). Cerebellar GABAergic progenitors adopt an external granule cell-like phenotype in the absence of Ptf1a transcription factor expression. Proc. Natl. Acad. Sci. USA 104, 5193-5198. (Pubitemid 47186198)
51. 12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin. Br. J. Cancer 104, 1038-1048.
52. Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H. et al. (2012). EMT and dissemination precede pancreatic tumor formation. Cell 148, 349-361.
53. Rodini, C. O., Suzuki, D. E., Nakahata, A. M., Pereira, M. C., Janjoppi, L., Toledo, S. R. and Okamoto, O. K. (2010). Aberrant signaling pathways in medulloblastomas: a stem cell connection. Arq. Neuropsiquiatr. 68, 947-952.
54. Salnikov, A. V., Liu, L., Platen, M., Gladkich, J., Salnikova, O., Ryschich, E., Mattern, J., Moldenhauer, G., Werner, J., Schemmer, P. et al. (2012). Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential. PLoS ONE 7, e46391.
55. Satelli, A. and Li, S. (2011). Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell. Mol. Life Sci. 68, 3033-3046.
56. Savagner, P. (2010). The epithelial-mesenchymal transition (EMT) phenomenon. Ann. Oncol. 21 Suppl. 7, vii89-vii92.
57. Scanlon, C. S., Van Tubergen, E. A., Inglehart, R. C. and D'Silva, N. J. (2013). Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J. Dent. Res. 92, 114-121.
58. Sellick, G. S., Barker, K. T., Stolte-Dijkstra, I., Fleischmann, C., Coleman, R. J., Garrett, C., Gloyn, A. L., Edghill, E. L., Hattersley, A. T., Wellauer, P. K. et al. (2004). Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat. Genet. 36, 1301-1305. (Pubitemid 39577939)
59. Spatuzza, C., Schiavone, M., Di Salle, E., Janda, E., Sardiello, M., Fiume, G., Fierro, O., Simonetta, M., Argiriou, N., Faraonio, R. et al. (2008). Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk. Nucleic Acids Res. 36, 4402-4416.
60. Stanger, B. Z., Stiles, B., Lauwers, G. Y., Bardeesy, N., Mendoza, M., Wang, Y., Greenwood, A., Cheng, K. H., McLaughlin, M., Brown, D. et al. (2005). Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell 8, 185-195. (Pubitemid 41317590)
61. Stoletov, K. and Klemke, R. (2008). Catch of the day: zebrafish as a human cancer model. Oncogene 27, 4509-4520.
62. Su, Y., Büchler, P., Gazdhar, A., Giese, N., Reber, H. A., Hines, O. J., Giese, T., Büchler, M. W. and Friess, H. (2006). Pancreatic regeneration in chronic pancreatitis requires activation of the notch signaling pathway. J. Gastrointest. Surg. 10, 1230-1242. (Pubitemid 44781199)
63. Tiso, N., Filippi, A., Pauls, S., Bortolussi, M. and Argenton, F. (2002). BMP signalling regulates anteroposterior endoderm patterning in zebrafish. Mech. Dev. 118, 29-37. (Pubitemid 35292119)
64. Truty, M. J. and Urrutia, R. (2007). Basics of TGF-beta and pancreatic cancer. Pancreatology 7, 423-435.
65. Ungefroren, H., Groth, S., Sebens, S., Lehnert, H., Gieseler, F. and Fändrich, F. (2011). Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1. Mol. Cancer 10, 67.
66. Virtanen, S., Alarmo, E. L., Sandström, S., Ampuja, M. and Kallioniemi, A. (2011). Bone morphogenetic protein -4 and -5 in pancreatic cancer - novel bidirectional players. Exp. Cell Res. 317, 2136-2146.
67. Wan, H., Korzh, S., Li, Z., Mudumana, S. P., Korzh, V., Jiang, Y. J., Lin, S. and Gong, Z. (2006). Analyses of pancreas development by generation of gfp transgenic zebrafish using an exocrine pancreas-specific elastaseA gene promoter. Exp. Cell Res. 312, 1526-1539.
68. Wang, Z., Banerjee, S., Li, Y., Rahman, K. M., Zhang, Y. and Sarkar, F. H. (2006a). Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res. 66, 2778-2784.
69. Wang, Z., Zhang, Y., Li, Y., Banerjee, S., Liao, J. and Sarkar, F. H. (2006b). Downregulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol. Cancer Ther. 5, 483-493.
70. Wu, S. M., Choo, A. B., Yap, M. G. and Chan, K. K. (2010). Role of Sonic hedgehog signaling and the expression of its components in human embryonic stem cells. Stem Cell Res. 4, 38-49.
71. Wu, Q., Miele, L., Sarkar, F. H. and Wang, Z. (2012). The role of EMT in pancreatic cancer progression. Pancreat. Disord. Ther. 2, 1000e121.
72. Xu, X., Browning, V. L. and Odorico, J. S. (2011). Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells. Mech. Dev. 128, 412-427.
73. Yang, Y. (2012). Wnt signaling in development and disease. Cell Biosci 2, 14.
74. Zecchin, E., Mavropoulos, A., Devos, N., Filippi, A., Tiso, N., Meyer, D., Peers, B., Bortolussi, M. and Argenton, F. (2004). Evolutionary conserved role of ptf1a in the specification of exocrine pancreatic fates. Dev. Biol. 268, 174-184. (Pubitemid 38367859)
75. Zhou, B., Liu, Y., Kahn, M., Ann, D. K., Han, A., Wang, H., Nguyen, C., Flodby, P., Zhong, Q., Krishnaveni, M. S. et al. (2012). Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). J. Biol. Chem. 287, 7026-7038